Table 5 Medications and invasive procedures used in treatment of the studied patients

Medications

High dose steroid (n = 113)

63(75.9)

50 (29.9)

< 0.001*

Usual steroid dose

20 (24.1)

120 (70.6)

< 0.001*

Prolonged steroid use (> 3 week) (n = 42)

27 (32.5)

15 (8.8)

< 0.001*

Tocilizumab (n = 63)

41(49.4)

22(12.9)

< 0.001*

Antibiotic use

83 (100)

170(100)

Antibiotic combination

61(73.5)

74 (43.5)

0.01*

Duration of antibiotic use

11 ± 7.4

7 ± 2.7

0.02*

Invasive devices

Noninvasive MV (n = 135)

68(81.9)

67(39.4)

0.04*

Invasive MV (n = 85)

62(74.7)

23 (13.5)

< 0.001*

Central venous line

57 (68.8)

31(18.2)

0.001*

Parenteral nutrition

47 (56.6)

31(18.2)

0.008*

Length of hospital stay: median (range)

13.5 (2–47)

6.9 (2–24)

< 0.001*